Rivulet Media Inc (fka RIVU)

[Lymans]

Feng Lin, MD, PhD – Director of Research

Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) is based in San Diego, California and is a publicly trade company biotechnology company focused on the development of regenerative medicine therapies and tools. The Company is specifically focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to lung, heart, circulatory system and other internal organs.

Meet the Bio-Matrix Management Team

Feng Lin, MD, PhD – Director of Research
Dr. Feng Lin has a strong background in drug/DNA in vivo delivery, oncology and tumor immunotherapy, cell and molecular biology, and animal model work. He also has extensive experience with tissue imaging, and stem cell differentiation. Previously, Dr. Lin was a Senior Research Scientist, Research & Development with Inovio BC, San Diego and Postdoctoral Fellow in the Burnham Institute for Medical Research, La Jolla. He received his M.D. from Central South University Xiangya School of Medicine, Changsha, China, along with a M.S. Biochemistry & Molecular Biology and a Ph.D. Hematology & Physiology from the same institution. Dr. Lin's research work has been widely published in international scientific journals.

http://www.bmsn.us/index.php?option=com_content&view=article&id=43&Itemid=53